Evidence map›Paper›PMID 34106502›Full record

ArticleHuman brain mapping2021

Characterizing white matter alterations subject to clinical laterality in drug-naïve de novo Parkinson's disease.

Yiming Xiao, Terry M Peters, Ali R Khan

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Gene expression asymmetry in Parkinson's disease: variation ofFrontiers in molecular neuroscience · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Yiming XiaoDepartment of Computer Science and Software Engineering, Concordia University, Montreal, Canada.ORCID 0000-0002-0962-3525
Terry M PetersImaging Research Laboratories, Robarts Research Institute, Western University, London, Canada.ORCID 0000-0003-1440-7488
Ali R KhanImaging Research Laboratories, Robarts Research Institute, Western University, London, Canada.ORCID 0000-0002-0760-8647
Western University · CAConcordia University · US

Funding

CIHR
6 · The paper itself

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder that is characterized by a range of motor and nonmotor symptoms, often with the motor dysfunction initiated unilaterally. Knowledge regarding disease-related alterations in white matter pathways can effectively help improve the understanding of the disease and propose targeted treatment strategies. Microstructural imaging techniques, including diffusion tensor imaging (DTI), allows inspection of white matter integrity to study the pathogenesis of various neurological conditions. Previous voxel-based analyses with DTI measures, such as fractional anisotropy and mean diffusivity have uncovered changes in brain regions that are associated with PD, but the conclusions were inconsistent, partially due to small patient cohorts and the lack of consideration for clinical laterality onset, particularly in early PD. Fixel-based analysis (FBA) is a recent framework that offers tract-specific insights regarding white matter health, but very few FBA studies on PD exist. We present a study that reveals strengthened and weakened white matter integrity that is subject to symptom laterality in a large drug-naïve de novo PD cohort using complementary DTI and FBA measures. The findings suggest that the disease gives rise to tissue degeneration and potential re-organization in the early stage.

Indexed as

Diffusion Tensor ImagingAgedCohort StudiesFemaleHumansMaleMiddle AgedParkinson DiseaseWhite Matterasymmetrydiffusion MRIDTI metricsfixel-based analysismicrostructureParkinson's diseasevoxel-based analysiswhite matter

Identifiers

PMID34106502
PMCPMC8410564
OpenAlexW3166979605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.